X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3917) 3917
Publication (264) 264
Book Review (40) 40
Book Chapter (11) 11
Magazine Article (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2708) 2708
male (1891) 1891
female (1482) 1482
animals (1278) 1278
middle aged (1158) 1158
surgery (1088) 1088
index medicus (1076) 1076
aged (991) 991
saphenous vein - drug effects (968) 968
cardiac & cardiovascular systems (919) 919
saphenous vein - transplantation (883) 883
peripheral vascular disease (756) 756
in vitro techniques (750) 750
coronary artery bypass (674) 674
saphenous-vein (631) 631
treatment outcome (620) 620
adult (585) 585
muscle, smooth, vascular - drug effects (566) 566
pharmacology & pharmacy (533) 533
dogs (528) 528
time factors (468) 468
saphenous vein (458) 458
dose-response relationship, drug (409) 409
muscle contraction - drug effects (356) 356
saphenous vein - metabolism (341) 341
norepinephrine - pharmacology (340) 340
saphenous vein - physiology (340) 340
vasoconstriction - drug effects (323) 323
saphenous vein - surgery (288) 288
rats (278) 278
follow-up studies (276) 276
cells, cultured (275) 275
endothelium, vascular - drug effects (268) 268
aged, 80 and over (264) 264
endothelium (251) 251
stents (247) 247
saphenous vein - pathology (246) 246
respiratory system (245) 245
atherosclerosis (242) 242
rabbits (242) 242
risk factors (242) 242
coronary angiography (232) 232
coronary artery bypass - adverse effects (231) 231
saphenous vein - diagnostic imaging (224) 224
muscle, smooth, vascular - physiology (221) 221
disease (209) 209
prospective studies (209) 209
vasoconstrictor agents - pharmacology (203) 203
graft occlusion, vascular - etiology (201) 201
cardiology and cardiovascular medicine (200) 200
vasodilation - drug effects (199) 199
retrospective studies (197) 197
vascular patency (192) 192
coronary artery bypass - methods (191) 191
analysis (185) 185
electric stimulation (178) 178
muscle, smooth, vascular - metabolism (172) 172
saphenous vein - physiopathology (169) 169
saphenous vein - cytology (168) 168
vasodilator agents - pharmacology (163) 163
drug-eluting stents (159) 159
bypass grafts (158) 158
intimal hyperplasia (155) 155
serotonin - pharmacology (155) 155
internal mammary artery (153) 153
graft occlusion, vascular - therapy (152) 152
angioplasty (150) 150
cardiovascular system (150) 150
mammary arteries - drug effects (150) 150
expression (147) 147
human saphenous-vein (147) 147
endothelium, vascular - physiology (141) 141
graft occlusion, vascular - prevention & control (141) 141
varicose veins (141) 141
vasoconstriction (141) 141
physiology (138) 138
follow-up (137) 137
grafts (136) 136
hematology (136) 136
percutaneous coronary intervention (135) 135
abridged index medicus (134) 134
muscle, smooth, vascular - cytology (134) 134
blood vessel prosthesis (133) 133
endothelium, vascular - metabolism (132) 132
varicose veins - surgery (131) 131
nitric-oxide (130) 130
smooth-muscle (129) 129
arteries (128) 128
care and treatment (127) 127
saphenous-vein grafts (124) 124
hyperplasia (123) 123
norepinephrine - metabolism (123) 123
biochemistry & molecular biology (121) 121
coronary disease - surgery (120) 120
phenylephrine - pharmacology (118) 118
recurrence (118) 118
health aspects (117) 117
stent (117) 117
patency (116) 116
nitric oxide (115) 115
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3850) 3850
French (20) 20
German (19) 19
Japanese (12) 12
Russian (11) 11
Spanish (5) 5
Italian (4) 4
Ukrainian (3) 3
Chinese (2) 2
Portuguese (2) 2
Czech (1) 1
Polish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2004, Volume 40, Issue 1, pp. 146 - 153
Purpose Current strategies to create small-diameter vascular grafts involve seeding biocompatible, compliant scaffolds with autologous vascular cells. Our... 
SURGERY | CELLS | MATRIX | ARTERIES | GRAFTS | PERFORMANCE | PERIPHERAL VASCULAR DISEASE | XENOGRAFTS | Tissue Engineering - methods | Extracellular Matrix - drug effects | Humans | Sodium Dodecyl Sulfate - pharmacology | Antigens, Surface - pharmacology | Saphenous Vein - physiopathology | Blood Vessel Prosthesis | Saphenous Vein - drug effects
Journal Article
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2015, Volume 64, Issue 1, pp. 210 - 218
Journal Article
Circulation, ISSN 0009-7322, 2010, Volume 122, Issue 25, pp. 2680 - 2687
Journal Article
Diabetologia, ISSN 0012-186X, 8/2010, Volume 53, Issue 8, pp. 1761 - 1771
Endothelial cells (ECs) and smooth muscle cells (SMCs) play key roles in the development of intimal hyperplasia in saphenous vein (SV) bypass grafts. In... 
Human | Smooth muscle cell | Endothelial cell | Human Physiology | Migration | Metabolic Diseases | Internal Medicine | Proliferation | Signalling | Insulin | Neointima | Medicine & Public Health | Saphenous vein | C-peptide | Sterol regulatory element binding transcription factor 1 | SIGNALING PATHWAYS | INTERNAL MAMMARY ARTERY | DIABETES-MELLITUS | IN-VITRO | INTIMAL HYPERPLASIA | BYPASS SURGERY | BALLOON INJURY | DISEASE | ENDOCRINOLOGY & METABOLISM | SMOOTH-MUSCLE-CELLS | Muscle, Smooth, Vascular - metabolism | Cell Count | Humans | Myocytes, Smooth Muscle - pathology | Endothelium, Vascular - drug effects | Saphenous Vein - metabolism | Hyperplasia - drug therapy | Phosphorylation - drug effects | Myocytes, Smooth Muscle - drug effects | Proto-Oncogene Proteins c-akt - metabolism | C-Peptide - metabolism | Myocytes, Smooth Muscle - metabolism | Hyperplasia - metabolism | Muscle, Smooth, Vascular - drug effects | Insulin - pharmacology | Endothelial Cells - metabolism | Cells, Cultured | Saphenous Vein - pathology | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Hyperplasia - pathology | Tunica Intima - drug effects | Tunica Intima - metabolism | Cell Movement - drug effects | Insulin - metabolism | Muscle, Smooth, Vascular - pathology | Tunica Intima - pathology | Analysis of Variance | Signal Transduction - drug effects | Endothelium, Vascular - metabolism | Endothelium, Vascular - pathology | Cell Proliferation - drug effects | RNA, Small Interfering | Endothelial Cells - pathology | Saphenous Vein - drug effects | Endothelial Cells - drug effects | Prevention | Hyperglycemia | Anopheles | Coronary artery bypass | Endothelium
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2016, Volume 64, Issue 2, pp. 471 - 478
Journal Article
Vascular Pharmacology, ISSN 1537-1891, 12/2017, Volume 99, pp. 34 - 44
Neointimal hyperplasia is a product of VSMC replication and consequent accumulation within the blood vessel wall. In this study, we determined whether... 
Vein graft | In-stent restenosis | Vascular smooth muscle | CK2 | Atherosclerosis | PRH | HUMAN SAPHENOUS-VEIN | PROLIFERATION | IN-VITRO | PLASMINOGEN-ACTIVATOR | GENE | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | HEX | GROWTH-FACTOR | TRANSCRIPTION FACTOR | EXPRESSION | Phosphorylation | Homeodomain Proteins - metabolism | Humans | Hyperplasia | Myocytes, Smooth Muscle - pathology | Casein Kinase II - genetics | Neointima | Transfection | RNA Interference | Saphenous Vein - enzymology | Myocytes, Smooth Muscle - drug effects | Muscle, Smooth, Vascular - drug effects | Human Umbilical Vein Endothelial Cells - drug effects | Myocytes, Smooth Muscle - enzymology | Tissue Culture Techniques | Casein Kinase II - antagonists & inhibitors | Cells, Cultured | Rats | Saphenous Vein - pathology | Transcription Factors - genetics | Homeodomain Proteins - genetics | Transcription Factors - metabolism | Proline-Rich Protein Domains | Muscle, Smooth, Vascular - pathology | Animals | Human Umbilical Vein Endothelial Cells - enzymology | Signal Transduction - drug effects | Cell Cycle Checkpoints - drug effects | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Mutation | Muscle, Smooth, Vascular - enzymology | Casein Kinase II - metabolism | Saphenous Vein - drug effects | Medical colleges | Platelet-derived growth factor | Proline | Fibroblast growth factors | Protein kinases | Endothelium | VSMC, vascular smooth muscle cell | DMEM, Dulbecco's modified essential medium | pfu, plaque forming units | PDGF-BB, platelet-derived growth factor-BB | siRNA, silencing RNA | FCS, foetal calf serum | HSaVECs, human saphenous vein endothelial cells | BCA, Bicinchoninic Acid | bFGF, basic fibroblast growth factor | Hhex, haematopoietically expressed homeobox | K66, 1-carboxymethyl-2-dimethylamino-4,5,6,7-tetrabromo-benzimidazole | PRH, proline-rich homeodomain | Hex | HUVECs, human umbilical ven endothelial cells | SDS, sodium dodecyl sulphate | TBB, 4,5,6,7-tetrabromobenzotriazole
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2014, Volume 74, Issue 100, pp. 240 - 250
Abstract Type 2 diabetes (T2DM) promotes premature atherosclerosis and inferior prognosis after arterial reconstruction. Vascular smooth muscle cells (SMC)... 
Cardiovascular | Type 2 diabetes | microRNA-143/145 | TGFβ | smooth muscle cell | differentiation | Smooth muscle cell | Differentiation | MicroRNA-143/145 | EPIGENETIC MECHANISMS | CARDIAC & CARDIOVASCULAR SYSTEMS | ATHEROSCLEROTIC PLAQUES | METABOLIC MEMORY | TGFB | DOWN-REGULATION | CELL BIOLOGY | VASCULAR COMPLICATIONS | INTENSIVE GLYCEMIC CONTROL | BYPASS SURGERY | TRANSFORMING GROWTH-FACTOR-BETA-1 | GENE-EXPRESSION | CARDIOVASCULAR-DISEASE | Muscle, Smooth, Vascular - metabolism | Diabetes Mellitus, Type 2 - genetics | Humans | Middle Aged | Actins - metabolism | Myocytes, Smooth Muscle - pathology | Myosin Heavy Chains - genetics | Male | MicroRNAs - metabolism | Diabetes Mellitus, Type 2 - metabolism | Myosin Heavy Chains - metabolism | Actins - genetics | Saphenous Vein - metabolism | Kruppel-Like Transcription Factors - metabolism | Aged, 80 and over | Adult | Female | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - metabolism | Muscle, Smooth, Vascular - drug effects | Hypoglycemic Agents - therapeutic use | Gene Expression Regulation | Saphenous Vein - pathology | Glucose - pharmacology | Transforming Growth Factor beta - pharmacology | Tumor Necrosis Factor-alpha - pharmacology | Muscle, Smooth, Vascular - pathology | Phenotype | Glucose - metabolism | Aged | MicroRNAs - genetics | Diabetes Mellitus, Type 2 - pathology | Primary Cell Culture | Diabetes Mellitus, Type 2 - drug therapy | Interleukin-1alpha - pharmacology | Kruppel-Like Transcription Factors - genetics | Saphenous Vein - drug effects | Diabetics | Myosin | Smooth muscle | Genetic aspects | Muscle proteins | Transforming growth factors | microRNA-143 | 145 | Original
Journal Article